These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36758860)

  • 1. Worsening tricuspid regurgitation after ICD implantation is rather due to transvenous lead than natural progression.
    Breeman KTN; Peijster AJL; De Bruin-Bon HACM; Pepplinkhuizen S; Van der Stuijt W; De Veld JA; Beurskens NEG; Stuiver MM; Wilde AAM; Tjong FVY; Knops RE
    Int J Cardiol; 2023 Apr; 376():76-80. PubMed ID: 36758860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation.
    Fanari Z; Hammami S; Hammami MB; Hammami S; Shuraih M
    J Electrocardiol; 2015; 48(5):791-7. PubMed ID: 26216371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worsening tricuspid regurgitation associated with permanent pacemaker and implantable cardioverter-defibrillator implantation: A systematic review and meta-analysis of more than 66,000 subjects.
    Alnaimat S; Doyle M; Krishnan K; Biederman RWW
    Heart Rhythm; 2023 Nov; 20(11):1491-1501. PubMed ID: 37506990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions.
    Arabi P; Özer N; Ateş AH; Yorgun H; Oto A; Aytemir K
    Cardiol J; 2015; 22(6):637-44. PubMed ID: 26412607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ventricular pacing lead position on tricuspid regurgitation: A randomized prospective trial.
    Schleifer JW; Pislaru SV; Lin G; Powell BD; Espinosa R; Koestler C; Thome T; Polk L; Li Z; Asirvatham SJ; Cha YM
    Heart Rhythm; 2018 Jul; 15(7):1009-1016. PubMed ID: 29496605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricuspid Regurgitation Following Implantation of Endocardial Leads: Incidence and Predictors.
    Lee RC; Friedman SE; Kono AT; Greenberg ML; Palac RT
    Pacing Clin Electrophysiol; 2015 Nov; 38(11):1267-74. PubMed ID: 26234305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.
    Höke U; Auger D; Thijssen J; Wolterbeek R; van der Velde ET; Holman ER; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    Heart; 2014 Jun; 100(12):960-8. PubMed ID: 24449717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiography-guided Cardiac Implantable Electronic Device Implantation to Reduce Device Related Tricuspid Regurgitation: A Prospective Controlled Study.
    Marincheva G; Levi T; Perelshtein Brezinov O; Valdman A; Rahkovich M; Kogan Y; Laish-Farkash A
    Isr Med Assoc J; 2022 Jan; 24(1):25-32. PubMed ID: 35077042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonapical Right Ventricular Pacing Is Associated with Less Tricuspid Valve Interference and Long-Term Progress of Tricuspid Regurgitation.
    Yu YJ; Chen Y; Lau CP; Liu YX; Wu MZ; Chen YY; Ho LM; Tse HF; Yiu KH
    J Am Soc Echocardiogr; 2020 Nov; 33(11):1375-1383. PubMed ID: 32828623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transvenous Extraction of Pacemaker and Defibrillator Leads and the Risk of Tricuspid Valve Regurgitation.
    Park SJ; Gentry JL; Varma N; Wazni O; Tarakji KG; Mehta A; Mick S; Grimm R; Wilkoff BL
    JACC Clin Electrophysiol; 2018 Nov; 4(11):1421-1428. PubMed ID: 30466846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Implantable Cardioverter-Defibrillator Leads on the Tricuspid Valve and Right Ventricle: A Randomized Trial.
    Leong DP; Dokainish H; Mondésert B; Cavalli G; Khetan A; Cirne F; Baro Vila R; Klimis H; De Jesus TA; AlGhasab NS; Akbari V; Suliman A; Eltebi O; Almhri A; Ferdous T; Djuric A; Bashir J; Krahn AD; Exner DV; Philippon F; Birne DH; Joza J; Healey JS
    JACC Clin Electrophysiol; 2024 Sep; 10(9):2088-2096. PubMed ID: 39001765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Right Ventricular Pacing on Right Ventricular Mechanics and Tricuspid Regurgitation in Patients With High-Grade Atrioventricular Block and Sinus Rhythm (from the Protection of Left Ventricular Function During Right Ventricular Pacing Study).
    Saito M; Iannaccone A; Kaye G; Negishi K; Kosmala W; Marwick TH;
    Am J Cardiol; 2015 Dec; 116(12):1875-82. PubMed ID: 26517949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
    Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
    Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation.
    Nazmul MN; Cha YM; Lin G; Asirvatham SJ; Powell BD
    Europace; 2013 Mar; 15(3):409-13. PubMed ID: 23193162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution and prognosis of tricuspid and mitral regurgitation following cardiac implantable electronic devices: a systematic review and meta-analysis.
    Yuyun MF; Joseph J; Erqou SA; Kinlay S; Echouffo-Tcheugui JB; Peralta AO; Hoffmeister PS; Boden WE; Yarmohammadi H; Martin DT; Singh JP
    Europace; 2024 Jul; 26(7):. PubMed ID: 38812433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Features of Lead-Induced Tricuspid Regurgitation in Patients With Heart Failure Events After Cardiac Implantation of Electronic Devices　- A Three-Dimensional Echocardiographic Study.
    Nakajima H; Seo Y; Ishizu T; Iida N; Sato K; Yamamoto M; Machino-Ohtsuka T; Nogami A; Ohte N; Ieda M
    Circ J; 2020 Nov; 84(12):2302-2311. PubMed ID: 33071243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, Predictors, and Prognostic Value of Residual Tricuspid Regurgitation in Patients With Left Ventricular Assist Device.
    Nakanishi K; Homma S; Han J; Takayama H; Colombo PC; Yuzefpolskaya M; Garan AR; Farr MA; Kurlansky P; Di Tullio MR; Naka Y; Takeda K
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29937432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tricuspid regurgitation and implantable devices.
    Al-Bawardy R; Krishnaswamy A; Rajeswaran J; Bhargava M; Wazni O; Wilkoff B; Tuzcu EM; Martin D; Thomas J; Blackstone E; Kapadia S
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):259-66. PubMed ID: 25377489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, Risk Factors, and Prognosis of Tricuspid Regurgitation After Cardiac Implantable Electronic Device Implantation: A Systematic Review and Meta-analysis.
    Zhang XX; Wei M; Xiang R; Lu YM; Zhang L; Li YD; Zhang JH; Xing Q; Tu-Erhong ZK; Tang BP; Zhou XH
    J Cardiothorac Vasc Anesth; 2022 Jun; 36(6):1741-1755. PubMed ID: 34389210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.